InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2024-06-05 00:00:00 ET · period of report 2024-05-31 · accession 0001127602-24-017961 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-05 2024-05-31 DNA Coen Steven P. See remarks M - OptEx — +29.7K 186.0K +19% —
D 2024-06-05 2024-06-03 DNA Coen Steven P. See remarks S - Sale+OE $0.55 -13.4K 178.8K -7% -$7,392
DM 2024-06-05 2024-05-31 DNA Coen Steven P. See remarks M - OptEx — -29.7K 281.3K -10% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-05-31 M A 6,249 — 192,272 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Common Class A Common Stock 2024-06-03 S D 13,440 $0.55 178,832 D — —
3 Common Class A Common Stock 2024-05-31 M A 23,496 — 186,023 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2024-05-31 M D 23,496 — 822,369 D — · — to — 23,496 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2024-05-31 M D 6,249 — 281,251 D — · — to — 6,249 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.